no statement of use filed
on 25 Mar 2019
Last Applicant/ Owned by
3-15, Edobori, 1-chome, Nishi-ku,
Osaka
JP
Serial Number
86891245 filed on 29th Jan 2016
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, se Read More
Pharmaceutical preparations for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress.; veterinary preparations for Companion animals, farm animals, dogs, cats, horses, chickens, cattle and pigs for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress; pharameutical agents affecting digestive organs; pharmaceutical preparations for skin care for animals; medicines for veterinary purposes for Companion animals, farm animals, dogs, cats, horses, chickens, cattle and pigs for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress
No 86891245
No Service/Collective Mark
No 1035-1314
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
25th Mar 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
25th Mar 2019 | ABANDONMENT - NO USE STATEMENT FILED |
28th Jul 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
26th Jul 2018 | EXTENSION 3 FILED |
26th Jul 2018 | EXTENSION 3 GRANTED |
26th Jul 2018 | TEAS EXTENSION RECEIVED |
17th Feb 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
15th Feb 2018 | EXTENSION 2 GRANTED |
15th Feb 2018 | EXTENSION 2 FILED |
15th Feb 2018 | TEAS EXTENSION RECEIVED |